These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
371 related articles for article (PubMed ID: 23966684)
21. Breathing abnormalities in a female mouse model of Rett syndrome. Johnson CM; Cui N; Zhong W; Oginsky MF; Jiang C J Physiol Sci; 2015 Sep; 65(5):451-9. PubMed ID: 26071253 [TBL] [Abstract][Full Text] [Related]
22. MeCP2-mediated alterations of striatal features accompany psychomotor deficits in a mouse model of Rett syndrome. Kao FC; Su SH; Carlson GC; Liao W Brain Struct Funct; 2015 Jan; 220(1):419-34. PubMed ID: 24218106 [TBL] [Abstract][Full Text] [Related]
23. Radically truncated MeCP2 rescues Rett syndrome-like neurological defects. Tillotson R; Selfridge J; Koerner MV; Gadalla KKE; Guy J; De Sousa D; Hector RD; Cobb SR; Bird A Nature; 2017 Oct; 550(7676):398-401. PubMed ID: 29019980 [TBL] [Abstract][Full Text] [Related]
24. Wild-type microglia arrest pathology in a mouse model of Rett syndrome. Derecki NC; Cronk JC; Lu Z; Xu E; Abbott SB; Guyenet PG; Kipnis J Nature; 2012 Mar; 484(7392):105-9. PubMed ID: 22425995 [TBL] [Abstract][Full Text] [Related]
25. Defects in brainstem neurons associated with breathing and motor function in the Mecp2R168X/Y mouse model of Rett syndrome. Johnson CM; Zhong W; Cui N; Wu Y; Xing H; Zhang S; Jiang C Am J Physiol Cell Physiol; 2016 Dec; 311(6):C895-C909. PubMed ID: 27653984 [TBL] [Abstract][Full Text] [Related]
26. Fluoxetine rescues rotarod motor deficits in Mecp2 heterozygous mouse model of Rett syndrome via brain serotonin. Villani C; Sacchetti G; Carli M; Invernizzi RW Neuropharmacology; 2020 Oct; 176():108221. PubMed ID: 32652084 [TBL] [Abstract][Full Text] [Related]
27. Dendrimer nanotherapy targeting of glial dysfunction improves inflammation and neurobehavioral phenotype in adult female Mecp2-heterozygous mouse model of Rett syndrome. Khoury ES; Patel RV; O'Ferrall C; Fowler A; Sah N; Sharma A; Gupta S; Scafidi S; Kurtz JS; Olmstead SJ; Kudchadkar SR; Kannan RM; Blue ME; Kannan S J Neurochem; 2024 May; 168(5):841-854. PubMed ID: 37777475 [TBL] [Abstract][Full Text] [Related]
28. Activation of the Medial Prefrontal Cortex Reverses Cognitive and Respiratory Symptoms in a Mouse Model of Rett Syndrome. Howell CJ; Sceniak MP; Lang M; Krakowiecki W; Abouelsoud FE; Lad SU; Yu H; Katz DM eNeuro; 2017; 4(6):. PubMed ID: 29333487 [TBL] [Abstract][Full Text] [Related]
29. Motor, Somatosensory, Viscerosensory and Metabolic Impairments in a Heterozygous Female Rat Model of Rett Syndrome. Bhattacherjee A; Winter MK; Eggimann LS; Mu Y; Gunewardena S; Liao Z; Christianson JA; Smith PG Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29286317 [TBL] [Abstract][Full Text] [Related]
30. Neuroanatomy in mouse models of Rett syndrome is related to the severity of Mecp2 mutation and behavioral phenotypes. Allemang-Grand R; Ellegood J; Spencer Noakes L; Ruston J; Justice M; Nieman BJ; Lerch JP Mol Autism; 2017; 8():32. PubMed ID: 28670438 [TBL] [Abstract][Full Text] [Related]
31. Deciphering Rett syndrome with mouse genetics, epigenomics, and human neurons. Tao J; Wu H; Sun YE Int Rev Neurobiol; 2009; 89():147-60. PubMed ID: 19900619 [TBL] [Abstract][Full Text] [Related]
32. Reversibility of functional deficits in experimental models of Rett syndrome. Cobb S; Guy J; Bird A Biochem Soc Trans; 2010 Apr; 38(2):498-506. PubMed ID: 20298210 [TBL] [Abstract][Full Text] [Related]
33. Anti-Semaphorin 4D Rescues Motor, Cognitive, and Respiratory Phenotypes in a Rett Syndrome Mouse Model. Mao Y; Evans EE; Mishra V; Balch L; Eberhardt A; Zauderer M; Gold WA Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502373 [TBL] [Abstract][Full Text] [Related]
34. Pharmacological reactivation of inactive X-linked Przanowski P; Wasko U; Zheng Z; Yu J; Sherman R; Zhu LJ; McConnell MJ; Tushir-Singh J; Green MR; Bhatnagar S Proc Natl Acad Sci U S A; 2018 Jul; 115(31):7991-7996. PubMed ID: 30012595 [TBL] [Abstract][Full Text] [Related]
35. Targeted delivery of an Mecp2 transgene to forebrain neurons improves the behavior of female Mecp2-deficient mice. Jugloff DG; Vandamme K; Logan R; Visanji NP; Brotchie JM; Eubanks JH Hum Mol Genet; 2008 May; 17(10):1386-96. PubMed ID: 18223199 [TBL] [Abstract][Full Text] [Related]
36. Safety and efficacy of genetic MECP2 supplementation in the R294X mouse model of Rett syndrome. Collins BE; Merritt JK; Erickson KR; Neul JL Genes Brain Behav; 2022 Jan; 21(1):e12739. PubMed ID: 33942492 [TBL] [Abstract][Full Text] [Related]
37. Elevating expression of MeCP2 T158M rescues DNA binding and Rett syndrome-like phenotypes. Lamonica JM; Kwon DY; Goffin D; Fenik P; Johnson BS; Cui Y; Guo H; Veasey S; Zhou Z J Clin Invest; 2017 May; 127(5):1889-1904. PubMed ID: 28394263 [TBL] [Abstract][Full Text] [Related]
38. MeCP2 SUMOylation rescues Mecp2-mutant-induced behavioural deficits in a mouse model of Rett syndrome. Tai DJ; Liu YC; Hsu WL; Ma YL; Cheng SJ; Liu SY; Lee EH Nat Commun; 2016 Feb; 7():10552. PubMed ID: 26842955 [TBL] [Abstract][Full Text] [Related]
39. Cerebellar gene expression profiles of mouse models for Rett syndrome reveal novel MeCP2 targets. Jordan C; Li HH; Kwan HC; Francke U BMC Med Genet; 2007 Jun; 8():36. PubMed ID: 17584923 [TBL] [Abstract][Full Text] [Related]
40. Selective preservation of cholinergic MeCP2 rescues specific Rett-syndrome-like phenotypes in MeCP2 Zhou H; Wu W; Zhang Y; He H; Yuan Z; Zhu Z; Zhao Z Behav Brain Res; 2017 Mar; 322(Pt A):51-59. PubMed ID: 28093257 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]